IP Library Assignment 022277/0160
Patent Assignment
Reel/Frame 022277/0160

Assignment of Assignor's Interest

Recorded: 2009-02-18 Pages: 7
Assignor
NOVO NORDISK A/S
Executed: 2008-12-19
Assignee
SAPPHIRE THERAPEUTICS
1160 U.S. HIGHWAY 22, SUITE 104, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (18)
Compounds with Growth Hormone Releasing Properties
Patent: 5,854,211 →
Application: 08/464,679 →
Compounds with Growth Hormone Releasing Properties
Patent: 5,977,178 →
Application: 08/769,020 →
Compounds with Growth Hormone Releasing Properties
Patent: 5,919,777 →
Application: 08/842,187 →
Compounds with Growth Hormone Releasing Properties
Patent: 5,922,770 →
Application: 08/896,550 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,013,658 →
Application: 08/897,239 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,127,341 →
Application: 09/088,690 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,127,391 →
Application: 09/218,686 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,083,908 →
Application: 09/228,300 →
Salt Forms of (2E)-5-Amino-5-Methylhex-2-Enoic Acid N-Methyl-N-((1R)-1-(N-Methyl-N-((1R)-1-(Methylcarbamoyl)-2-Phenylethyl )Carbamoyl)-2-(2-Naphthyl)Ethyl)Amide
Patent: 6,281,247 →
Application: 09/256,427 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,127,354 →
Application: 09/270,862 →
Method for Prepairing a Compound with Growth Hormone Releasing Properties
Patent: 6,784,158 →
Application: 09/325,677 →
Stable Pharmaceutical Formulation
Patent: 6,525,084 →
Application: 09/358,024 →
Publication: US 2002/0022649
Compounds with Growth Hormone Releasing Properties
Patent: 6,566,337 →
Application: 09/431,864 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,350,767 →
Application: 09/443,993 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,555,570 →
Application: 09/534,135 →
Publication: US 2003/0040483
Compounds with growth hormone releasing properties
Patent: 6,274,584 →
Application: 09/619,227 →
Compounds with Growth Hormone Releasing Properties
Patent: 6,939,880 →
Application: 10/067,895 →
Publication: US 2003/0055261
Growth Hormone Secretagogue Receptor Type 1A Agonists
Patent: 7,994,329 →
Application: 11/424,885 →
Publication: US 2007/0066540
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 4, 1996
From: JOHANSEN, NILS LANGELAND; LAU, JESPER; MADSEN, KJELD; LUNDT, BEHREND FRIEDRICH
To: NOVO NORDISK A/S
Reel/Frame 008120/0609 →
Assignment of Assignor's Interest May 5, 1997
From: HANSEN, THOMAS KRUSE; PESCHKE, BERND; LAU, JESPER; LUNDT, BEHREND FRIEDRICH
To: NOVO NORDISK A/S
Reel/Frame 008492/0829 →
Assignment of Assignor's Interest Oct 20, 1997
From: HANSEN, THOMAS KRUSE; PESCHKE, BERND; ANDERSEN, KNUD ERIK
To: NOVO NORDISK A/S
Reel/Frame 008764/0400 →
Assignment of Assignor's Interest Dec 23, 1997
From: PESCHKE, BERND; ANKERSEN, MICHAEL; HANSEN, THOMAS KRUSE; THOGERSEN, HENNING
To: NOVO NORDISK A/S
Reel/Frame 008859/0593 →
Assignment of Assignor's Interest Jan 16, 1998
From: LAU, JESPER; PESCHKE, BERND; HANSEN, THOMAS KRUSE; JOHANSEN, NILS LANGELAND
To: NOVO NORDISK A/S
Reel/Frame 008911/0749 →
Assignment of Assignor's Interest Jul 28, 1998
From: HANSEN, THOMAS KRUSE; LAU, KESPER; PESCHKE, BERND; ANKERSEN, MICHAEL
To: NOVO NORDISK A/S
Reel/Frame 009354/0827 →
Assignment of Assignor's Interest Feb 22, 1999
From: ANKERSEN, MICHAEL
To: NOVO NORDISK A/S
Reel/Frame 009779/0461 →
Assignment of Assignor's Interest Apr 5, 1999
From: JESSEN, CLAUS ULRICH
To: NOVO NORDISK A/S
Reel/Frame 009874/0551 →
Assignment of Assignor's Interest Jul 12, 1999
From: JESSEN, CLAUS ULRICH
To: NOVO NORDISK A/S
Reel/Frame 010080/0946 →
Assignment of Assignor's Interest Sep 13, 1999
From: RASMUSSEN, STELLA RUDKJAER; GRONLUND, PER
To: NOVO NORDISK A/S
Reel/Frame 010223/0995 →
Assignment of Assignor's Interest Feb 1, 2000
From: RICHTER, BIRGIT
To: NOVO NORDISK A/S
Reel/Frame 010590/0194 →
Assignment of Assignor's Interest Feb 3, 2000
From: ANKERSEN, MICHAEL
To: NOVO NORDISK A/S
Reel/Frame 010592/0912 →
Assignment of Assignor's Interest Nov 20, 2006
From: ANDERSEN, MAIBRITT BANSHOLM; HANSEN, BIRGIT SEHESTED; RAUN, KIRSTEN; TULLIN, SOREN
To: NOVO NORDISK A/S
Reel/Frame 018556/0043 →
Merger Jan 14, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023778/0301 →
Merger Jan 29, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0787 →
Assignment of Assignor's Interest Jan 29, 2010
From: ANKERSON, MICHAEL
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0734 →
Corrective Assignment to Correct the Spelling of Assignor's Name and to Correct the Name of the Assignee Previously Recorded on Reel 023869 Frame 0734. Assignor(S) Hereby Confirms the Assignor's Name Should Have Been: Michael Ankersen; and the Assignee's Name Should Have Been: Novo Nordisk A/S. Feb 1, 2010
From: ANKERSEN, MICHAEL
To: NOVO NORDISK A/S
Reel/Frame 023951/0611 →
Assignment of Assignor's Interest Oct 28, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 036903/0809 →
Corrective Assignment to Correct the Country of the Assignee's Address Previously Recorded on Reel 036903 Frame 0809. Assignor(S) Hereby Confirms the Correct Country of the Assignee's Address. Dec 14, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 037288/0749 →